Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1980 May 1;151(5):1232–1244. doi: 10.1084/jem.151.5.1232

Lymphocyte cooperation is required for amplification of macrophage procoagulant activity

PMCID: PMC2185847  PMID: 7373220

Abstract

Murine splenic lymphoid cells have been shown to possess basal procoagulant activity. This activity was localized to most macrophages by assay of cell populations, as well as by a direct plaque assay that permitted identification of expressed procoagulant activity of individual viable cells as well as content. Both content and viable expression of procoagulant activity was markedly increased by exposure to bacterial lipopolysaccharide, reaching a maximum after 6 h. The quantitative increase in procoagulant activity content and viable expression was limited to the macrophage population. Separated populations of lymphocytes or macrophages could not be stimulated by lipopolysaccharide to increase procoagulant activity, whereas the addition of lymphocytes to macrophages at a 3-4:1 ratio maximally reconstituted the amplification of procoagulant activity. Further evidence of cellular collaboration followed from observation that only lymphocytes that had been exposed to lipopolysaccharide were capable of triggering the increase in macrophage procoagulant activity. This appears to represent a new form of lymphocyte-macrophage cooperation in an effector pathway that may participate in some forms of immunologic responses and contribute to the phenotypic features of certain immunologic tissue lesions.

Full Text

The Full Text of this article is available as a PDF (953.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ciznár I., Shands J. W., Jr Effect of alkali-treated lipopolysaccharide on erythrocyte membrane stability. Infect Immun. 1971 Oct;4(4):362–367. doi: 10.1128/iai.4.4.362-367.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cohen S., Benacerraf B., McCluskey R. T., Ovary Z. Effect of anticoagulants on delayed hypersensitivity reactions. J Immunol. 1967 Feb;98(2):351–358. [PubMed] [Google Scholar]
  3. Colvin R. B., Dvorak H. F. Role of the clotting system in cell-mediated hypersensitivity. II. Kinetics of fibrinogen/fibrin accumulation and vascular permeability changes in tuberculin and cutaneous basophil hypersensitivity reactions. J Immunol. 1975 Jan;114(1 Pt 2):377–387. [PubMed] [Google Scholar]
  4. Colvin R. B., Mosesson M. W., Dvorak H. F. Delayed-type hypersensitivity skin reactions in congenital afibrinogenemia lack fibrin deposition and induration. J Clin Invest. 1979 Jun;63(6):1302–1306. doi: 10.1172/JCI109425. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Garg S. K., Niemetz J. Tissue factor activity of normal and leukemic cells. Blood. 1973 Nov;42(5):729–735. [PubMed] [Google Scholar]
  6. Grinnell F., Milam M., Srere P. A. Studies on cell adhesion. II. Adhesion of cells to surfaces of diverse chemical composition and inhibition of adhesion by sulfhydryl binding reagents. Arch Biochem Biophys. 1972 Nov;153(1):193–198. doi: 10.1016/0003-9861(72)90436-5. [DOI] [PubMed] [Google Scholar]
  7. Lerner R. G., Goldstein R., Cummings G., Lange K. Stimulation of human leukocyte thromboplastic activity by endotoxin. Proc Soc Exp Biol Med. 1971 Oct;138(1):145–148. doi: 10.3181/00379727-138-35848. [DOI] [PubMed] [Google Scholar]
  8. Li C. Y., Lam K. W., Yam L. T. Esterases in human leukocytes. J Histochem Cytochem. 1973 Jan;21(1):1–12. doi: 10.1177/21.1.1. [DOI] [PubMed] [Google Scholar]
  9. McGhee J. R., Farrar J. J., Michalek S. M., Mergenhagen S. E., Rosenstreich D. L. Cellular requirements for lipopolysaccharide adjuvanticity. A role for both T lymphocytes and macrophages for in vitro responses to particulate antigens. J Exp Med. 1979 Apr 1;149(4):793–807. doi: 10.1084/jem.149.4.793. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Morgan E. L., Weigle W. O. The requirement for adherent cells in the Fc fragment-induced proliferative response of murine spleen cells. J Exp Med. 1979 Aug 1;150(2):256–266. doi: 10.1084/jem.150.2.256. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Morrison D. C., Leive L. Fractions of lipopolysaccharide from Escherichia coli O111:B4 prepared by two extraction procedures. J Biol Chem. 1975 Apr 25;250(8):2911–2919. [PubMed] [Google Scholar]
  12. Muhlfelder T. W., Niemetz J., Kreutzer D., Beebe D., Ward P. A., Rosenfeld S. I. C5 chemotactic fragment induces leukocyte production of tissue factor activity: a link between complement and coagulation. J Clin Invest. 1979 Jan;63(1):147–150. doi: 10.1172/JCI109269. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Nemerson Y., Pitlick F. A. The tissue factor pathway of blood coagulation. Prog Hemost Thromb. 1972;1:1–37. [PubMed] [Google Scholar]
  14. Niemetz J., Fani K. Role of leukocytes in blood coagulation and the generalized Shwartzman reaction. Nat New Biol. 1971 Aug 25;232(34):247–248. doi: 10.1038/newbio232247a0. [DOI] [PubMed] [Google Scholar]
  15. Niemetz J., Marcus A. J. The stimulatory effect of platelets and platelet membranes on the procoagulant activity of leukocytes. J Clin Invest. 1974 Dec;54(6):1437–1443. doi: 10.1172/JCI107891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Paterson P. Y. Experimental allergic encephalomyelitis: role of fibrin deposition in immunopathogenesis of inflammation in rats. Fed Proc. 1976 Nov;35(13):2428–2434. [PubMed] [Google Scholar]
  17. Rickles F. R., Hardin J. A., Pitlick F. A., Hoyer L. W., Conrad M. E. Tissue factor activity in lymphocyte cultures from normal individuals and patients with hemophilia A. J Clin Invest. 1973 Jun;52(6):1427–1434. doi: 10.1172/JCI107316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Rickles F. R., Levin J., Hardin J. A., Barr C. F., Conrad M. E., Jr Tissue factor generation by human mononuclear cells: effects of endotoxin and dissociation of tissue factor generation from mitogenic response. J Lab Clin Med. 1977 Apr;89(4):792–803. [PubMed] [Google Scholar]
  19. Rivers R. P., Hathaway W. E., Weston W. L. The endotoxin-induced coagulant activity of human monocytes. Br J Haematol. 1975 Jul;30(3):311–316. doi: 10.1111/j.1365-2141.1975.tb00547.x. [DOI] [PubMed] [Google Scholar]
  20. Rothberger H., Zimmerman T. S., Spiegelberg H. L., Vaughan J. H. Leukocyte procoagulant activity: enhancement of production in vitro by IgG and antigen-antibody complexes. J Clin Invest. 1977 Mar;59(3):549–557. doi: 10.1172/JCI108670. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Rothberger H., Zimmerman T. S., Vaughan J. H. Increased production and expression of tissue thromboplastin-like procoagulant activity in vitro by allogeneically stimulated human leukocytes. J Clin Invest. 1978 Sep;62(3):649–655. doi: 10.1172/JCI109172. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Schwartz H. J., Leskowitz S. The effect of carrageenan on delayed hypersensitivity reactions. J Immunol. 1969 Jul;103(1):87–91. [PubMed] [Google Scholar]
  23. Tzehoval E., Segal S., Feldman M. Thymus-derived lymphocytes control the expression of immunogenic properties of peritoneal macrophages. Proc Natl Acad Sci U S A. 1979 Aug;76(8):4056–4060. doi: 10.1073/pnas.76.8.4056. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. VASSALLI P., MCCLUSKEY R. T. THE PATHOGENIC ROLE OF FIBRIN DEPOSITION IN IMMUNOLOGICALLY INDUCED GLOMERULONEPHRITIS. Ann N Y Acad Sci. 1964 Aug 27;116:1052–1062. doi: 10.1111/j.1749-6632.1964.tb52567.x. [DOI] [PubMed] [Google Scholar]
  25. Watson J., Riblet R. Genetic control of responses to bacterial lipopolysaccharides in mice. II. A gene that influences a membrane component involved in the activation of bone marrow-derived lymphocytes by lipipolysaccharides. J Immunol. 1975 May;114(5):1462–1468. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES